Baumgardner in JMCP: Is OCM Episode-Based Spending Associated with Patient Outcomes?
PHE Senior Research Economist James Baumgardner, PhD, and colleagues conducted an analysis aimed at determining whether spending within oncology care episodes is associated with survival. Researchers utilized evidence from geographic variations in spending and individual-level survival. The results were recently published in the Journal of Managed Care & Specialty Pharmacy (2018;24:504-513).
To read recent press coverage of Dr. Baumgartner’s study, as well as the study itself, please click below:
In this unique one-hour webinar, Dr. Jena outlines a broader framework for assessing value to improve identification of not only the highest-value treatments, but also low-value therapies on which spending can safely be reduced.